Articles

Impact of Early Incorporation of Nutrition Interventions as a Component of Cancer Therapy

Publication Date: 04 November 2020

Author(s): Julie Richards, Mary Beth Arensberg, Sara Thomas, Kirk W. Kerr, Refaat Hegazi, and Michael Bastasch.

Abstract:

This article, published in the open-access journal Nutrients, evaluated current trends in the literature and reported evidence around the timing and impact of specific nutrition interventions in oncology patients undergoing active cancer treatment. The identified studies examined the impacts of nutrition interventions (nutrition counseling, oral nutrition supplements, or combination of both) on a variety of cancer diagnoses. 

Author Bio(s):

Julie Richards, MS, RDN

Nutrition Consultant
Abbott Nutrition
Columbus, Ohio
USA

Mary Beth Arensberg, PhD, RDN, LDN, FAND

Director Health Policy & Programs
Abbott Nutrition
Columbus, Ohio, USA

Sara Thomas, PHD, RD

Research Scientist Global Adult Nutrition Science
Abbott Nutrition Division of Abbott
Columbus, OH, USA

Kirk W Kerr, PhD

Senior Manager, Health Economics
Abbott Nutrition
Columbus, OH, USA

Kirk W Kerr, PhD, joined Abbott Nutrition’s Health Economics and Outcomes Research team in June 2019. While at Abbott, Kirk has researched the impact of nutrition-focused Quality Improvement programs in inpatient, outpatient, and surgical care settings. Before joining Abbott, Kirk worked in the FDA’s Center for Drug Evaluation and Research researching the impact of FDA policies on drug development, drug prices, and patient access to medicines. While at the FDA, he also provided economic support for the FDA’s Generic Drug User Fee (GDUFA) and Biosimilar User Fee (BsUFA) negotiating teams. He also worked as an economic consultant on antitrust and intellectual property matters. Kirk has a PhD and MA in Economics from Ohio State University, and BS and MA in Economics from the University of Missouri.

 

 

Refaat Hegazi, MD, PhD, MS, MPH, MBA

Head of Global Medical Affairs
Director of Scientific and Medical External Engagement
Abbott Nutrition
Columbus, Ohio
USA

Michael D Bastasch, MD

Medical Director
University of Texas Health/East Texas Cancer Institute
Athens, Texas, USA

Dr Michael D Bastasch is the medical director and a radiation oncologist at the University of Texas Health/East Texas Cancer Institute in Athens, Texas, US. He received his medical degree from the University of Kansas School of Medicine in Kansas City, Kansas, US. He completed his residency in radiation oncology at Baylor College of Medicine in Houston, Texas. Dr Bastasch provides oversight and management for radiation oncology services in the treatment of approximately 170 adult patients each year. He practices community-based patient care for a large diverse population of patients, including pediatric, adult, geriatric, and mentally ill patients, and is results and outcome oriented. Dr Bastasch initiated the high dose rate program for gynecologic, breast, and prone breast technique. He has authored/coauthored many articles in peer-reviewed journals and presented at national and international conferences.

Category